Enhanced oral exposure of diltiazem by the concomitant use of naringin in rats

International Journal of Pharmaceutics

Volumn 305, Issue 1-2, 2005, Pages 122-128

  Choi, Jun Shik ^a   Han, Hyo Kyung ^a  

^a Chosun University   (South Korea)

Author keywords

Desacetyldiltiazem; Diltiazem; Naringin; Pharmacokinetics; Rat

Indexed keywords

AURANTIIN; DEACETYLDILTIAZEM; DILTIAZEM; FLAVONOID;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG METABOLISM; MALE; MOUTH CAVITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CALCIUM CHANNEL BLOCKERS; CYTOCHROME P-450 ENZYME SYSTEM; DILTIAZEM; DRUG INTERACTIONS; FLAVANONES; MALE; P-GLYCOPROTEIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 27644593975     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2005.09.004     Document Type: Article

References (26)

1. B. Ameer, and R.A. Weintraus Drug interactions with grapefruit juice Clin. Pharmacokinet. 31 1997 103 121
2. D.G. Bailey, J. Malcolm, O. Arnold, and J.D. Spence Grapefruit juice-drug interactions Br. J. Clin. Pharmacol. 46 1998 101 110
3. D.G. Bailey, J.H. Kreeft, C. Munoz, D.J. Freeman, and J.R. Bend Grapefruit juice-felodipine interaction: effect of naringin and 6′,7′-dihydroxybergamottin in humans Clin. Pharmacol. Ther. 64 1998 248 256
4. J.S. Choi, and S.C. Shin Enhanced paclitaxel bioavailability after oral coadministration of paclitaxel prodrug with naringin to rats Int. J. Pharm. 292 2005 149 156
5. H. Christensen, A. Asberg, A.-B. Holmboe, and K.J. Berg Coadministration of grapefruit juice increases systemic exposure of diltiazem in healthy volunteers Eur. J. Clin. Pharmacol. 58 2002 515 520
6. J. Duggan, W.S. Peterson, M. Schutz, S. Khuder, and J. Charkraborty Use of complementary and alternative therapies in HIV-infected patients AIDS Patient Care STDS. 15 2001 159 167
7. V.A. Eagling, L. Profit, and D.J. Back Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components Br. J. Clin. Pharmacol. 48 1999 543 552
8. A.M. Evans Influence of dietary components on the gastrointestinal metabolism and transport of drugs Ther. Drug Monit. 22 2000 131 136
9. U. Fuhr, and A.L. Kummert The fate of naringin in humans: a key to grapefruit juice-drug interactions? Clin. Pharmacol. Ther. 58 1995 365 373
10. K.J. Goebel, and E.U. Kolle High performance liquid chromatographic determination of diltiazem and four of its metabolites in plasma J. Chromatogr. 345 1985 355 363
11. P.C. Ho, D.J. Saville, P.F. Coville, and S. Wanwimolruk Content of CYP3A4 inhibitors, naringin, naringenin and bergapten in grapefruit and grapefruit juice products Pharm. Acta Helv. 74 2000 379 385
12. P. Hodek, P. Trefil, and M. Stiborova Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450 Chem. Biol. Interact. 139 2002 1 21
13. C. Ioannides Pharmacokinetic interactions between herbal remedies and medicinal drugs Xenobiotica 32 2002 451 478
14. G.C. Kane, and J.J. Lipsky Drug-grapefruit juice interactions Mayo Clin. Proc. 75 2000 933 942
15. D.H. Kim, E.A. Jung, I.S. Shong, and J.A. Han Intestinal bacterial metabolism of flavonoids and its relation to some biological activities Arch. Pharm. Res. 21 1998 17 23
16. Y.H. Lee, M.H. Lee, and C.K. Shim Pharmacokinetics of diltiazem and deacetyldiltiazem in rats Int. J. Pharm. 76 1991 71 76
17. A. Miniscalco, J. Lundahl, C.G. Regardh, B. Edgar, and U.G. Eriksson Inhibition of dihydropyridine metabolism in rat and human liver-microsomes by flavonoids found in grapefruit juice J. Pharmacol. Exp. Ther. 261 1992 1195 1199
18. H. Ni, C. Simile, and A.M. Hardy Utilization of complementary and alternative medicine by United States adults: results from the 1999 national health interview survey Med. Care. 40 2002 353 358
19. H. Sigusch, L. Henschel, H. Kraul, U. Merkel, and V. Hoffmann Lack of effect of grapefruit juice on diltiazem bioavailability in normal subjects Pharmazie. 49 1994 675 679
20. H. Takanaga, A. Ohnishi, H. Matsuo, and Y. Sawada Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in Caco-2 cells Biol. Pharm. Bull. 21 1998 1062 1066
21. T.H. Tsai, C.H. Lee, and P.H. Yeh Effect of P-glycoprotein modulators on the pharmacokinetics of camptothecin using microdialysis Br. J. Pharmacol. 134 2001 1245 1252
22. P.K.F. Yeung, S.J. Mosher, M.A. Quilliam, and T.J. Montague Species comparison of pharmacokinetics and metabolism of diltiazem in humans, dogs, rabbits, and rats Drug Metab. Dispos. 18 1990 1055 1059
23. H. Zhang, C.W. Wong, P.F. Coville, and S. Wanwimolruk Effect of the grapefruit flavonoid naringin on pharmacokinetics of quinine in rats Drug Metabol. Drug Interact. 17 2000 351 363
24. Y.C. Zhang, and L.Z. Benet The gut as a barrier to drug absorption-combined role of cytochrome P450 3A and P-glycoprotein Clin. Pharmacokinet. 40 2001 159 168
25. S. Zhang, and M.E. Morris Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport J. Pharmacol. Exp. Ther. 304 2003 1258 1267
26. S. Zhou, L.Y. Lim, and B. Chowbay Herbal modulation of P-glycoprotein Drug Metab. Rev. 36 2004 57 104